Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Eligible patients had to have a BMI greater than or equal to 27 kg/m 2 and less than or equal to 45 kg/m 2 (there was no lower limit on BMI for patients with type 2 diabetes mellitus) and two or more of the following obesity-related co-morbid conditions: Patients ranged in age from 19 to71 years of age (mean age 51) and 70% were female
Because of its wide-ranging systemic effects, many mediated by gut microbial metabolites such as short-chain fatty acids (SCFAs), adequate dietary fiber intake is essential for maintaining homeostasis
In some studies, people taking Tirzepatide lost even more weight than those on Wegovy - around 20-25% of their starting body weight in some cases
Using available evidence, the ACP ranked obesity medications, placing semaglutide and tirzepatide first, followed by phentermine-topiramate, liraglutide, and naltrexone-bupropion for adults with obesity
US$ 25.58
US$ 20.16
US$ 20.11
US$ 28.00
US$ 28.77
US$ 28.66
US$ 21.14
